[at noodls] – SYDNEY, AUSTRALIA – Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD; ISIN: US74154B2034) (Prima, the Company) has announced today that Matthew Lehman, its Chief Executive Officer, will … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is hiring next, click here to view […]
[at noodls] – Ovarian Cancer About CVacâ„¢ Treatment Clinical Trials Announcements 23 January 2013 Quaterly Activity Report QUARTERLY ACTIVITY REPORT For Quarter ending 31 December 2012 Prima BioMed Ltd (Prima) (ASX: … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is hiring next, click here to view […]
[at noodls] – Announcements 20 December 2012 NOMURA: Quick Note: ONTY’s Stimuvax fails Phase 3 clinical trial ONTY’s Stimuvax fails Phase 3 clinical trial After its Phase 3 study of Stimuvax concluded, Merck KGaA (MRK … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboardSee who Prima is hiring next, click here […]
[at noodls] – Ovarian Cancer About CVacâ„¢ Treatment Clinical Trials Announcements 26 October 2012 QUARTERLY ACTIVITY REPORT QUARTERLY ACTIVITY REPORT For Quarter ending 30 September 2012 Prima BioMed Ltd (Prima) (ASX: … moreView todays social media effects on PBMDView the latest stocks trending across Twitter. Click to view dashboard […]
